OptimizeRx held Q3 2021 earnings call but transcript excerpt lacks financial details

OptimizeRx Corp

2021-Q3 EPS reported -$0.01 revenue$40,979,801

Conference call held on November 9, 2021 to discuss quarterly results.
Transcript attached as Exhibit 99.1, but provided text does not contain specific financial data.
No revenue, EPS, or guidance figures available from the exhibit excerpt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.